HER2 + GASTRIC CANCER
Clinical trials for HER2 + GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + GASTRIC CANCER trials appear
Sign up with your email to follow new studies for HER2 + GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Tough-to-Treat HER2 cancers, including brain spread
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new drug called IAM1363 for people with advanced cancers that have specific changes in a protein called HER2. The trial will enroll about 243 adults whose cancer has worsened after standard treatments, including …
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Triple-Threat therapy tested for aggressive stomach cancers
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or esophageal cancer that has spread. It's for patients who have not yet received treatment for their advanced cancer and whose tumors test positive for two specific markers (HER2 and PD-L1). The …
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC